The drug supply will be given to the federal government, which will then allocate it on a by-need basis across the country starting early next week, Gilead Sciences chairman and CEO Daniel O’Day said in the Sunday morning interview. “We’ve donated the entire supply...because we acknowledge and recognize the human suffering..and want to make ...